Abstract 13 A Randomized, Placebo-Controlled, Phase II Trial of Intravenous Allogeneic Umbilical Cord Blood Infusion for Adults with Ischemic Stroke
Publication
, Conference
Laskowitz, D; Poehlein, E; Schpall, E; Willson, J; Wingard, J; Freed, B; Belagaje, S; Khanna, A; Duarte, DV; Volpi, J; Marrotte, E; Troy, J ...
Published in: Stem Cells Translational Medicine
September 6, 2022
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Stem Cells Translational Medicine
DOI
EISSN
2157-6580
ISSN
2157-6564
Publication Date
September 6, 2022
Volume
11
Issue
Supplement_1
Start / End Page
S15 / S15
Publisher
Oxford University Press (OUP)
Related Subject Headings
- 4003 Biomedical engineering
- 3206 Medical biotechnology
- 1103 Clinical Sciences
- 1004 Medical Biotechnology
- 0601 Biochemistry and Cell Biology
Citation
APA
Chicago
ICMJE
MLA
NLM
Laskowitz, D., Poehlein, E., Schpall, E., Willson, J., Wingard, J., Freed, B., … Kurtzberg, J. (2022). Abstract 13 A Randomized, Placebo-Controlled, Phase II Trial of Intravenous Allogeneic Umbilical Cord Blood Infusion for Adults with Ischemic Stroke. In Stem Cells Translational Medicine (Vol. 11, pp. S15–S15). Oxford University Press (OUP). https://doi.org/10.1093/stcltm/szac057.013
Laskowitz, Daniel, Emily Poehlein, Elizabeth Schpall, Jeff Willson, John Wingard, Brian Freed, Samir Belagaje, et al. “Abstract 13 A Randomized, Placebo-Controlled, Phase II Trial of Intravenous Allogeneic Umbilical Cord Blood Infusion for Adults with Ischemic Stroke.” In Stem Cells Translational Medicine, 11:S15–S15. Oxford University Press (OUP), 2022. https://doi.org/10.1093/stcltm/szac057.013.
Laskowitz D, Poehlein E, Schpall E, Willson J, Wingard J, Freed B, et al. Abstract 13 A Randomized, Placebo-Controlled, Phase II Trial of Intravenous Allogeneic Umbilical Cord Blood Infusion for Adults with Ischemic Stroke. In: Stem Cells Translational Medicine. Oxford University Press (OUP); 2022. p. S15–S15.
Laskowitz, Daniel, et al. “Abstract 13 A Randomized, Placebo-Controlled, Phase II Trial of Intravenous Allogeneic Umbilical Cord Blood Infusion for Adults with Ischemic Stroke.” Stem Cells Translational Medicine, vol. 11, no. Supplement_1, Oxford University Press (OUP), 2022, pp. S15–S15. Crossref, doi:10.1093/stcltm/szac057.013.
Laskowitz D, Poehlein E, Schpall E, Willson J, Wingard J, Freed B, Belagaje S, Khanna A, Duarte DV, Volpi J, Marrotte E, Troy J, Kurtzberg J. Abstract 13 A Randomized, Placebo-Controlled, Phase II Trial of Intravenous Allogeneic Umbilical Cord Blood Infusion for Adults with Ischemic Stroke. Stem Cells Translational Medicine. Oxford University Press (OUP); 2022. p. S15–S15.
Published In
Stem Cells Translational Medicine
DOI
EISSN
2157-6580
ISSN
2157-6564
Publication Date
September 6, 2022
Volume
11
Issue
Supplement_1
Start / End Page
S15 / S15
Publisher
Oxford University Press (OUP)
Related Subject Headings
- 4003 Biomedical engineering
- 3206 Medical biotechnology
- 1103 Clinical Sciences
- 1004 Medical Biotechnology
- 0601 Biochemistry and Cell Biology